- Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone mythThe poet didn’t say “sing to me, Muse, of a man with optimized endocrine panels," writes urologist Elizabeth Dray.STAT · 3d ago↗ source
- Agios’ second shot at sickle cell disease falls shortAgios said it is dropping a next-generation sickle cell disease drug after lackluster results from a mid-stage trial. The drug, known as tebapivat, represented Agios’ second shot at the disease,…Endpoints · 3d ago↗ source
- Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’<p>The young venture firm, which has bet heavily on tech and biotech’s convergence, has now invested in 35 companies and recently saw one of them acquired by AI giant Anthropic.</p>BioPharma Dive · 3d ago